Mustang Bio, Inc. develops cell therapies for difficult-to-treat cancers. The company focuses on translating medical breakthroughs into next-generation therapies. It employs a model of in-licensing potential first-in-class therapeutic candidates from top institutions to reduce development risk and enhance the likelihood of success.
